Global Muscle Relaxant Drugs Market 2017-2021

Friday, April 7, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, April 6, 2017 /PRNewswire/ -- About Muscle Relaxant Drugs Muscle spasticity is caused by damage to the spinal

cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading
to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive reflexes. Severe cases can lead to deep disability, including an inability to straighten out joints. Download the full report:'s analysts forecast the global muscle relaxant drugs market to grow at a CAGR of 5.64% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global muscle relaxant drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The market is divided into the following segments based on geography: - Americas - APAC - EMEA Technavio's report, Global Muscle Relaxant Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors - Pfizer - Ipsen Group - Allergan - Novartis - Teva Pharmaceuticals Other prominent vendors - Acorda Therapeutics - Aldeyra Therapeutics - Canbex Therapeutics - Daewoong - Emcure Pharmaceuticals - Endo International - Fresenius Kabi - Galderma - INSYS Therapeutics - Johnson & Johnson - Lannett Company - Merz Pharma - Mylan - Par Pharmaceutical - PhytoTech Therapeutics - Revance Therapeutics - Sun Pharmaceutical Industries - Takeda Pharmaceutical Market driver - Presence of a large patient pool driving adoption rates. - For a full, detailed list, view our report Market challenge - Side effects associated with use of muscle relaxants hamper adoption rates. - For a full, detailed list, view our report Market trend - Advanced drug delivery technologies fuels adoption of muscle relaxants. - For a full, detailed list, view our report Key questions answered in this report - What will the market size be in 2021 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report. Methodology Download the full report: ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Email: Tel: +44 208 816 85 48 Website:

To view the original version on PR Newswire, visit:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store